41 results
Page 2 of 3
8-K
EX-99.1
guczfrnrx8 ljksw
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.2
ekwcx9ol
10 Jan 22
Passage Bio Announces 2022 Research and Clinical Development Goals to Advance Robust CNS Pipeline
8:00am
8-K
EX-99.2
7i9ohi80rm4a7 eq3cf
17 Dec 21
Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
7:01am
8-K
EX-99.2
j98xp4rx shgspq4
4 Nov 21
Passage Bio Reports Third Quarter 2021 Financial Results and Provides Recent Business Highlights
8:00am
8-K
EX-99.1
7vw8l5
4 Nov 21
Passage Bio Reports Third Quarter 2021 Financial Results and Provides Recent Business Highlights
8:00am
8-K
EX-99.1
cwjcu000v
4 Oct 21
Regulation FD Disclosure
7:31am
8-K
EX-99.1
coomc7n6ldkm
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
8-K
EX-99.2
sapx2e66z qe2vh5j
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
8-K
EX-99.2
vz7fvftc
5 May 21
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
7:00am
8-K
EX-99.1
br3os0stshra69ou4r
5 May 21
Passage Bio Reports First Quarter 2021 Financial Results and Recent Business Highlights
7:00am
8-K
EX-99.2
olqy9vf26ij8jhkl6vd
3 Mar 21
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
7:01am
8-K
EX-99.1
bssvcdftxqeklar0nj7
3 Mar 21
Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
7:01am
8-K
EX-99.2
jofaf23u
11 Jan 21
Passage Bio Announces Plan to Deliver on Multiple Meaningful Catalysts in 2021
7:15am
8-K
EX-10.1
5gkndfqk8 4l1r2ho5m
18 Dec 20
Entry into a Material Definitive Agreement
7:00am
8-K
EX-99.1
tzo97wfk3jx9syg
10 Nov 20
Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights
7:00am
8-K
EX-99.1
qjd4x4q7k2vb
9 Sep 20
Corporate Presentation SEPTEMBER 2020
7:00am
8-K
EX-99.1
c7blla
13 Aug 20
Passage Bio Reports Second Quarter 2020 Financial Results and Recent Business Highlights
7:15am
8-K
EX-99.1
xnf1f40dj6
11 May 20
Passage Bio Reports First Quarter 2020 Financial Results and Recent Business Highlights
7:30am
S-1
EX-10.6
cbws0
3 Feb 20
IPO registration
6:39am